Symbiosis is a global, client-focused, contract manufacturing organisation (CMO) offering GMP aseptic manufacture for pre-clinical, clinical and commercial supply including supporting services.
Symbiosis empowers drug developers to meet their project milestones through rapid access to fill-finish slots. Our purpose-built, FDA-inspected and MHRA-licensed manufacturing suites are designed for containment of highly potent products.

Working with liquid and lyophilised formulations, our expert in-house team has years of experience in taking a wide range of from drug substance to QP release - small molecules and biologics e.g. ATMPs, mAbs, RNA, proteins, peptides, vaccines, ADCs, drug conjugates. As a trusted partner, Symbiosis is dedicated to supporting our clients facilitate safe, life-saving injectable drug therapies, without delay. Get in touch to begin your fill-finish program.